期刊文献+

甲状腺转录因子1和p40在非小细胞肺癌肿瘤细胞共表达1例 被引量:4

Non-small cell lung carcinoma with diffuse coexpression of thyroid transcription factor-1 and p40 in the same tumor cells:report of a case
原文传递
导出
摘要 本文报道1例非小细胞肺癌,其肿瘤细胞罕见的共表达甲状腺转录因子1(TTF1)和p40,描述其临床病理特征并进行相关文献复习。检索到文献报道此类病例共6例(含本例在内),组织学均为高级别非小细胞肺癌,肿瘤细胞共同弥漫表达TTF1、p40,并且显示p53的突变或多态性,具有不良的生物学行为。肿瘤细胞共表达TTF1、p40且具有TP53改变的非小细胞肺癌可能是一种尚未被完全认识的具有侵袭性的独立肿瘤,这对改善肺癌的分类、评估预后以及可能的靶向治疗具有一定指导意义。
作者 陈冰 成娜 Bing Chen;Na Cheng(Department of Pathology,the Third Affiliated Hospital of Sun Yat-sen University Yuedong Hospital,Meizhou 514700,China;Department of Pathology,the Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,China)
出处 《中华病理学杂志》 CAS CSCD 北大核心 2022年第6期558-560,共3页 Chinese Journal of Pathology
基金 广州市科技计划-市校(院)联合资助(登峰医院)基础研究项目(202102010267) 中山大学附属第三医院国家自然科学基金培育专项资助项目-青年项目(2021GZRPYQN12)。
  • 相关文献

参考文献1

二级参考文献24

  • 1Muller PA, Vousden KH. Mutant PS3 in cancer: new functions and therapeutic opportunities. Cancer Cell, 2014, 25(3): 304-317.
  • 2Kandoth C, McLellan MD, Vandin F, et al. Mutational landscape and significance across 12 major cancer types. Nature, 2013, 502(7471): 333-339.
  • 3Hong B, van den Heuvel AP, Prabhu VV, et al. Targeting tumor suppressor P53 for cancer therapy: strategies, challenges and opportunities. Curr Drug Targets, 2014, 15(1): 80-89.
  • 4Tsao MS, Aviel-Ronen S, Ding K, et al. Prognostic and predictive importance of P53 and RAS for adjuvant chemotherapy in non small- cell lung cancer.J Clin Oncol, 2007, 25(33): 5240-5247.
  • 5Kosaka Tj Yatabe Yj Onozato R, et al. Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma. J Thorac Oncol, 2009, 4(1): 22-29.
  • 6Chien WP, Wong RH, Wu TC, et al. Potential increase in the prognostic value of P53 mutation by Pro72 allele in stage I non-small-cell lung cancer. Ann Surg Oncol, 2009, 16(7): 1918-1924.
  • 7Ahrendt SA, Hu Y, Buta M, et al. P53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study. J Natl Cancer lnst, 2003, 95(13): 961-970.
  • 8An SJj Chen ZH, Su J, et al. Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status. PLoS One, 2012, 7(6): e40109.
  • 9Imielinski M, Berger AH, Hammerman PS, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell, 2012, 150(6): 1107-1120.
  • 10Lipson D, Capelletti M, Yelensky R, et al. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med, 2012, 18(3): 382-384.

共引文献24

同被引文献6

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部